Allison Inserro

Allison is Associate Editorial Director for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®. She joined AJMC® in 2017. She produces and oversees written, video, and podcast content across several disease states and issues surrounding value-based care and health policy.

She has an MPA from New York University. You can connect with Allison on LinkedIn.

Articles by Allison Inserro

CMS announced a raft of proposed changes, including expanding its site-neutral payments between what Medicare pays for at physicians’ offices and off-campus hospital clinics, where rates are higher because of added hospital facility fees. The agency is also extending 340B drug discounts to off-site hospital clinics.

Patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who have short telomeres, a biomarker of aging, are more likely to have a worse quality of life and have a higher risk of exacerbations and death, according to a recent study, but daily azithromycin may help.

The shift to value-based care has stalled since 2017, according to a survey of health plan executive and providers commissioned by Quest Diagnostics. Quest said its third annual study suggests that physicians need better tools, like data access, and less complex quality measures to spur adoption of value-based healthcare, which focuses on care quality and patient outcomes rather than the quantity of services delivered.

The White House released a report saying the time is right to impose work requirements on 3 noncash welfare programs—food stamps, housing assistance, and Medicaid. Adding work requirements to these programs would reduce dependency upon them by nondisabled, working-age beneficiaries receiving such assistance, as poverty as fallen since the programs were created.

CMS cut the amount of money it is awarding to organizations that help individuals enroll in insurance for 2019 plans under the Affordable Care Act (ACA) by $26 million, and, for the first time, is encouraging the so-called “navigators” to also sign people up for health insurance that provides a narrower level of coverage than the plans under the ACA.

A day before legislators will hold hearings on 15 bills relating to the 340B drug discount program for hospitals, 340B Health, which represents those hospitals and providers, released a report that said more than half of the disproportionate share hospitals would lose eligibility under one Congressional proposal.

Payers and providers are looking to keep vulnerable patients in pain from becoming addicted to painkillers, but those who live with pain on a daily basis are understandably upset at the thought of losing access to medications they say keep them functional. Here are 5 takeaways from recent coverage about this important issue.

President Donald Trump’s trade war with China could mean an end to cooperation with the United States to stop the flow of synthetic opioids like fentanyl; Medicaid beneficiaries in Arkansas had until Thursday night to log onto computers to report their work activities or exemption status for the month in order for them to maintain health insurance; a report claims that the Trump administration is suppressing an Environmental Protection Agency draft health assessment that warns most Americans inhale enough formaldehyde vapor to put them at risk of developing leukemia and other illnesses.

Using a series of small public data sets, researchers found a positive association of prenatal exposure to folic acid fortification with subsequent cortical development in the brain—considered key for cognitive and mental health—through adolescence. The finding suggests that increased prenatal exposure to folic acid through food fortification may protect against psychosis through altered postnatal cortical development.

Researchers in China investigated the prevalence of bronchiectasis in different phenotypes of subjects with COPD and the correlation between bronchiectasis and different phenotypes, especially emphysema.



Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo